Recent Finacing
Recent Raise
Inflammatix is a molecular diagnostics company developing rapid point-of-care tests that read a patient’s immune response to distinguish bacterial from viral infections.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Inflammatix.